[{"indications": "Indications\u00a0see under Dose", "name": "MICAFUNGIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.2 Antifungal drugs", "5.2.4 Echinocandin antifungals"], "cautions": "Cautions\u00a0monitor renal function; interactions:  Appendix 1 (micafungin)Hepatotoxicity\u00a0Potentially life-threatening hepatotoxicity\r\nreported. Monitor liver function\u2014discontinue if significant and persistent abnormalities in liver\r\nfunction tests develop. Use with caution in hepatic impairment (avoid if severe) or if receiving other hepatotoxic drugs. Risk of hepatic side-effects greater in children under\r\n1 year of age", "side-effects": "Side-effects\u00a0nausea, vomiting, diarrhoea, abdominal pain; headache,\r\nfever; hypokalaemia, hypomagnesaemia, hypocalcaemia, leucopenia, anaemia;\r\nrash, phlebitis; less commonly dyspepsia, constipation,\r\nhepatomegaly, hepatitis and cholestasis (see also Hepatotoxicity above),\r\ntaste disturbances, anorexia, tachycardia, palpitation, bradycardia,\r\nblood pressure changes, flushing, dyspnoea, sleep disturbances, anxiety,\r\nconfusion, dizziness, tremor, pancytopenia, thrombocytopenia, eosinophilia,\r\nhyponatraemia, hypophosphataemia, hyperkalaemia, hyperhidrosis, and\r\npruritus; rarely haemolytic anaemia; also reported\r\nrenal failure (more frequent in children)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/201531.htm", "doses": ["By intravenous infusion, invasive\r\ncandidiasis, adult body-weight over\r\n40\u00a0kg, 100\u00a0mg once daily (increased to 200\u00a0mg daily if inadequate\r\nresponse) for at least 14 days; body-weight under 40\u00a0kg, 2\u00a0mg/kg once\r\ndaily (increased to 4\u00a0mg/kg daily if inadequate response) for at least\r\n14 days; child under 18 years see BNF for Children", "Oesophageal candidiasis, adult body-weight over 40\u00a0kg, 150\u00a0mg once daily; body-weight under 40\u00a0kg,\r\n3\u00a0mg/kg once daily; child 16\u201318 years\r\nsee BNF for Children", "Prophylaxis of candidiasis in patients undergoing bone-marrow\r\ntransplantation or who are expected to become neutropenic for over\r\n10 days, adult body-weight over 40\u00a0kg,\r\n50\u00a0mg once daily; body-weight under 40\u00a0kg, 1\u00a0mg/kg once daily; continue\r\nfor at least 7 days after neutrophil count in desirable range; child under 18 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless essential\u2014toxicity\r\nin animal studies"}]